NFL Biosciences【ALNFL】銘柄情報

NFL Biosciences SA (ALNFL) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

0.90

( 1.01% )

買値

0.89

売値

0.91

出来高

10,956

0.891 日の範囲 0.91

0.851 52 週間の範囲 1.846

時価総額

11.405M

前日終値

0.891

始値

0.91

時刻

200

0.9

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

52,061 €

発行済株式数

12,672,242

配当利回り

PER

-3.73

1 株当たり利益 (EPS)

-0.26

歳入

188

純利益

-3.32M

NFL Biosciences SA, a biotechnology company, engages in the development of botanical drugs in France. The company’s pipeline includes NFL-101, a drug candidate for smoking cessation, currently under Phase 2b clinical trials; and NFL-301, a drug candidate for reducing alcohol consumption which is in ... NFL Biosciences SA, a biotechnology company, engages in the development of botanical drugs in France. The company’s pipeline includes NFL-101, a drug candidate for smoking cessation, currently under Phase 2b clinical trials; and NFL-301, a drug candidate for reducing alcohol consumption which is in preclinical stage. It has scientific collaboration with McLean Hospital to deepen the understanding of the mechanism of action of NFL-101, its proprietary botanical drug candidate for smoking cessation. NFL Biosciences SA was incorporated in 2006 and is headquartered in Castelnau-le-Lez, France. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

www.nflbiosciences.com

本社

Castelnau-le-lez, France

設立

2026

NFL Biosciences SA is listed in the Healthcare sector of the ユーロネクスト with ticker ALNFL. The last closing price for NFL Biosciences was 0.89 €. Over the last year, NFL Biosciences shares have traded in a share price range of 0.851 € to 1.846 €.

NFL Biosciences currently has 12,672,242 shares in issue. The market capitalisation of NFL Biosciences is 11.41 € million. NFL Biosciences has a price to earnings ratio (PE ratio) of -3.73.

NFL Biosciences Announces the Publication of the Results of Its Phase II Clinical Trial CESTO II Evaluating NFL-101 in Smoking Cessation in Nicotine & Tobacco Research, the Official Journal of the Society for Research on Nicotine and Tobacco (SRNT)

The SRNT, the world’s leading scientific society dedicated to nicotine and tobacco research, publishes the results of the CESTO II study in its...

NFL Biosciences obtient des premiers financements non-dilutifs de 1,2 M€, s’ajoutant à sa récente augmentation de capital, pour poursuivre le développement de NFL-101, son traitement first in class contre l’addiction au tabac

Une « Aide à l'innovation » sous forme d’avance récupérable de 600 000 € accordée par Bpifrance Des emprunts bancaires pour 600 000 € octroyés...

NFL BIOSCIENCES : DÉPÔT D’UNE DEMANDE DE BREVET AUX ÉTATS-UNIS DÉDIÉE À LA RÉDUCTION DE LA CONSOMMATION D’ALCOOL AVEC NFL-301 & PRÉPARATION D’UNE DEMANDE DE PRE-IND AUPRÈS DE LA FDA

NFL BIOSCIENCES : DÉPÔT D’UNE DEMANDE DE BREVET AUX ÉTATS-UNIS DÉDIÉE À LA RÉDUCTION DE LA CONSOMMATION D’ALCOOL AVEC NFL-301 & PRÉPARATION...

BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITÉ : 1er SEMESTRE 2023

BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITÉ : 1er SEMESTRE 2023 BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITÉ : 1er SEMESTRE 2023 Au titre du...

NFL BIOSCIENCES : RENFORCEMENT D’UN ACTIONNAIRE FONDATEUR PAR EXERCICE DE BSPCE

NFL BIOSCIENCES : RENFORCEMENT D’UN ACTIONNAIRE FONDATEUR PAR EXERCICE DE BSPCE NFL BIOSCIENCES : RENFORCEMENT D’UN ACTIONNAIRE FONDATEUR PAR...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.025	-2.7027027027	0.925	0.96	0.891	31391	0.92424573	DE
4	0.01	1.12359550562	0.89	1.15	0.86	85515	0.9826745	DE
12	-0.156	-14.7727272727	1.056	1.15	0.86	54092	1.00802667	DE
26	-0.154	-14.6110056926	1.054	1.846	0.86	80045	1.24322078	DE
52	-0.256	-22.1453287197	1.156	1.846	0.851	67168	1.23578225	DE
156	-2.265	-71.5639810427	3.165	3.31	0.851	60774	1.87214026	DE
260	-3.1	-77.5	4	5	0.548	53637	1.97916403	DE